Mergers & Acquisitions Contracts & Agreements in the Biotechnology Industry

714 Contracts & Agreements

Browse by Subcategory

Joint Venture Agreements (37 contracts from 24 companies)
Merger Agreements (651 | 298)
Plan of Reorganization Agreements (26 | 17)

Browse by Company

AbbVie Inc. (4 contracts)
ABEONA THERAPEUTICS INC. (4)
ACCELERON PHARMA INC (1)
ACHIEVE LIFE SCIENCES, INC. (3)
Acorda Therapeutics (3)
Adamas Pharmaceuticals Inc (1)
Adaptimmune Therapeutics PLC (2)
Adhera Therapeutics, Inc. (2)
ADiTx Therapeutics, Inc. (10)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (3)
Advaxis, Inc. (4)
Aeglea BioTherapeutics, Inc. (3)
AgeX Therapeutics, Inc. (2)
AILERON THERAPEUTICS INC (1)
Aimmune Therapeutics, Inc. (1)
AKCEA THERAPEUTICS, INC. (1)
Akebia Therapeutics, Inc. (2)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (1)
Aldeyra Therapeutics, Inc. (1)
Alexion Pharmaceuticals (9)
Alkermes plc. (1)
Allarity Therapeutics, Inc. (1)
Alliqua BioMedical, Inc. (9)
Allovir, Inc. (1)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (2)
Altimmune, Inc. (4)
Amgen Inc. (8)
AMICUS THERAPEUTICS, INC. (5)
AmpliPhi Biosciences Corp (3)
Anchiano Therapeutics Ltd. (1)
Anika Therapeutics (2)
APPLIED GENETIC TECHNOLOGIES CORP (1)
Applied Molecular Transport Inc. (1)
Aprea Therapeutics, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
Aravive, Inc. (1)
ARCA biopharma, Inc. (6)
ARENA PHARMACEUTICALS INC (1)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (3)
Arsanis, Inc. (3)
ARYA Sciences Acquisition Corp II (3)
ASSEMBLY BIOSCIENCES, INC. (1)
Athenex, Inc. (2)
ATOSSA GENETICS INC (1)
AVEO PHARMACEUTICALS INC (1)
Avid Bioservices, Inc. (2)
AVROBIO, Inc. (1)
Ayala Pharmaceuticals, Inc. (1)
AzurRx BioPharma, Inc. (2)
Beam Therapeutics Inc. (1)
BeiGene, Ltd. (1)
Big Cypress Acquisition Corp. (1)
BIO-PATH HOLDINGS INC (2)
BioCardia, Inc. (4)
BIOCRYST PHARMACEUTICALS INC (1)
Biogen Inc. (3)
Biohaven Pharmaceutical Holding Co Ltd. (3)
BioRestorative Therapies, Inc. (2)
BIOSPECIFICS TECHNOLOGIES CORP (1)
BIOTIME INC (2)
BIOVIE INC. (1)
BIOXYTRAN, INC (4)
Bison Capital Acquisition Corp. (4)
Blueprint Medicines Corp (1)
Bone Biologics Corp (2)
BridgeBio Pharma, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (5)
Calyxt, Inc. (2)
CANCER GENETICS, INC (4)
CAPRICOR THERAPEUTICS, INC. (4)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
Capstone Therapeutics Corp. (2)
CareDx, Inc. (1)
CASI Pharmaceuticals, Inc. (3)
CASTLE BIOSCIENCES INC (2)
CATABASIS PHARMACEUTICALS INC (1)
CATALYST BIOSCIENCES, INC. (3)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (1)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (5)
Centessa Pharmaceuticals Ltd (1)
Century Therapeutics, Inc. (1)
Chanticleer Holdings, Inc. (4)
Chardan Healthcare Acquisition 2 Corp. (2)
Chardan Healthcare Acquisition Corp. (5)
Checkmate Pharmaceuticals, Inc. (1)
ChemoCentryx, Inc. (1)
CHIMERIX INC (1)
CLEVELAND BIOLABS INC (1)
CM Life Sciences III Inc. (3)
Coherus BioSciences, Inc. (2)
Comera Life Sciences Holdings, Inc. (1)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (1)
Constellation Alpha Capital Corp. (1)
CONSTELLATION PHARMACEUTICALS INC (1)
Corbus Pharmaceuticals Holdings, Inc. (1)
Cortexyme, Inc. (1)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
CRISPR Therapeutics AG (1)
CTD HOLDINGS INC (3)
CTI BIOPHARMA CORP (2)
Cullinan Oncology, LLC (1)
Cybrdi, Inc. (1)
CytoDyn Inc. (1)
CYTORI THERAPEUTICS, INC. (3)
CYTRX CORP (1)
Decibel Therapeutics, Inc. (1)
Deciphera Pharmaceuticals, Inc. (3)
DelMar Pharmaceuticals, Inc. (4)
Dermira, Inc. (1)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (6)
Digital Development Partners, Inc. (2)
Dynamics Special Purpose Corp. (2)
Edge Therapeutics, Inc. (4)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (4)
Eliem Therapeutics, Inc. (2)
Emerald Bioscience, Inc. (2)
Emergent BioSolutions Inc. (2)
Entasis Therapeutics Holdings Inc. (1)
Environmental Impact Acquisition Corp (2)
Epizyme, Inc. (1)
Equillium, Inc. (2)
Erasca, Inc. (1)
EVOLUTIONARY GENOMICS, INC. (2)
EXACT SCIENCES CORP (4)
Exelixis (1)
EXICURE, INC. (2)
Fibrocell Science, Inc. (1)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (3)
Flexion Therapeutics Inc (1)
FLUOROPHARMA MEDICAL, INC. (2)
Forma Therapeutics Holdings, Inc., (1)
Fortress Biotech, Inc. (3)
Forty Seven, Inc. (1)
Frequency Therapeutics, Inc. (1)
FS Development Corp. (2)
FS Development Corp. II (3)
G1 Therapeutics, Inc. (1)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (2)
GeoVax Labs, Inc. (2)
Gilead Sciences (12)
Global Blood Therapeutics, Inc. (1)
GLYCOMIMETICS INC (1)
Graphite Bio, Inc. (7)
Gritstone Oncology, Inc. (2)
GT Biopharma, Inc. (2)
GTX INC (2)
GX Acquisition Corp. (2)
HALOZYME THERAPEUTICS INC (1)
Harpoon Therapeutics, Inc. (1)
HEAT BIOLOGICS, INC. (1)
HedgePath Pharmaceuticals, Inc. (1)
HilleVax, Inc. (1)
HISTOGENICS CORP (2)
Homology Medicines, Inc. (2)
HST Global, Inc. (1)
Icosavax, Inc. (1)
IDERA PHARMACEUTICALS, INC. (3)
Imago BioSciences, Inc. (1)
Immix Biopharma, Inc. (1)
IMMUNE PHARMACEUTICALS INC (5)
ImmunoCellular Therapeutics, Ltd. (4)
IMMUNOGEN INC (1)
Immunome Inc. (1)
IMMUNOMEDICS INC (1)
Incyte (2)
Inhibrx, Inc. (1)
InMed Pharmaceuticals Inc. (4)
INOVIO PHARMACEUTICALS, INC. (1)
INSMED Inc (1)
Inspyr Therapeutics, Inc. (1)
Intec Pharma Ltd. (2)
INTERCEPT PHARMACEUTICALS, INC. (1)
INTREXON CORP (2)
Invitae Corp (11)
IONIS PHARMACEUTICALS INC (1)
IOVANCE BIOTHERAPEUTICS, INC. (1)
Isoray, Inc. (4)
Jounce Therapeutics, Inc. (1)
Kadmon Holdings, Inc. (1)
Karuna Therapeutics, Inc. (1)
KBL MERGER CORP. IV (4)
Kindred Biosciences, Inc. (2)
Kinnate Biopharma Inc. (1)
Kiromic Biopharma, Inc. (1)
KIWA BIO-TECH PRODUCTS GROUP CORP (1)
Kura Oncology, Inc. (2)
LA JOLLA PHARMACEUTICAL CO (7)
LEAP THERAPEUTICS, INC. (1)
Leisure Acquisition Corp. (2)
LifeSci Acquisition Corp. (2)
Ligand Pharmaceuticals Incorporated (16)
LogicBio Therapeutics, Inc. (1)
Lyell Immunopharma, Inc. (1)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (1)
MANHATTAN SCIENTIFICS INC (1)
MATEON THERAPEUTICS INC (5)
Matinas BioPharma Holdings, Inc. (2)
MEDICINOVA INC (2)
Medovex Corp. (2)
MEI Pharma, Inc. (1)
MeiraGTx Holdings plc (3)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (3)
MiMedx Group, Inc. (4)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (2)
Mirati Therapeutics, Inc. (1)
Molecular Templates, Inc. (1)
Moleculin Biotech, Inc. (1)
Momenta Pharmaceuticals, Inc. (1)
Morphic Holding, Inc. (1)
Myovant Sciences Ltd. (1)
Myriad Genetics, Inc. (3)
NantKwest, Inc. (4)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
Neurotrope, Inc. (6)
NEWLINK GENETICS CORP (3)
NOVAVAX INC (3)
NTN BUZZTIME INC (1)
NUTRA PHARMA CORP (1)
Ohr Pharmaceutical Inc (4)
Olivia Ventures, Inc. (1)
OncBioMune Pharmaceuticals, Inc (2)
OncoCyte Corp (4)
OPGEN INC (1)
Ophthotech Corp. (1)
Opko Health, Inc. (5)
Organicell Regenerative Medicine, Inc. (1)
Organogenesis Holdings Inc. (13)
ORGANOVO HOLDINGS, INC. (6)
Orgenesis Inc. (5)
Oyster Point Pharma, Inc. (1)
Pfenex Inc. (2)
PIERIS PHARMACEUTICALS, INC. (1)
PLURISTEM THERAPEUTICS INC (1)
POLARITYTE, INC. (2)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (3)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (1)
Progenics Pharmaceuticals, Inc. (3)
Prometheus Biosciences, Inc. (1)
Protagenic Therapeutics, Inc. (5)
Protalix BioTherapeutics, Inc. (1)
PROTEON THERAPEUTICS INC (2)
PROTEOSTASIS THERAPEUTICS, INC. (4)
PTC THERAPEUTICS, INC. (1)
PUMA BIOTECHNOLOGY, INC. (1)
Radius Health, Inc. (2)
Rasna Therapeutics Inc. (2)
REGENERX BIOPHARMACEUTICALS INC (1)
REGENXBIO Inc. (1)
Relay Therapeutics, Inc. (1)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (3)
REXAHN PHARMACEUTICALS, INC. (3)
Rezolute, Inc. (1)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (2)
Sana Biotechnology, Inc. (4)
SANGAMO THERAPEUTICS, INC (1)
Sarepta Therapeutics, Inc. (1)
Savara Inc (3)
SEATTLE GENETICS INC (2)
SELLAS Life Sciences Group, Inc. (2)
Sesen Bio, Inc. (1)
Sierra Oncology, Inc. (1)
Sigilon Therapeutics, Inc. (1)
Silverback Therapeutics, Inc. (3)
SOLENO THERAPEUTICS INC (2)
Solid Biosciences Inc. (5)
Sorrento Therapeutics, Inc. (12)
Spectrum Pharmaceuticals, Inc. (4)
SPHERIX INC (5)
Spinning Eagle Acquisition Corp. (4)
Spring Bank Pharmaceuticals, Inc. (3)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (1)
Surface Oncology, Inc. (1)
SYNLOGIC, INC. (4)
Synthetic Biologics, Inc. (1)
Syros Pharmaceuticals, Inc. (1)
Talaris Therapeutics, Inc. (1)
TCR2 THERAPEUTICS INC. (1)
TENAX THERAPEUTICS, INC. (1)
TG THERAPEUTICS, INC. (5)
Therapeutics Acquisition Corp. (1)
Tocagen Inc (1)
Translate Bio, Inc. (1)
Turning Point Therapeutics, Inc. (1)
TYME TECHNOLOGIES, INC. (1)
Ultragenyx Pharmaceutical Inc. (1)
United Therapeutics Corp (1)
Unum Therapeutics Inc. (1)
Vaccitech plc (3)
Vaxart, Inc. (5)
VERACYTE, INC. (2)
Vertex Pharmaceuticals Inc (2)
VICAL INC (2)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (1)
VistaGen Therapeutics, Inc. (2)
VITRO DIAGNOSTICS INC (1)
vTv Therapeutics Inc. (2)
WINDTREE THERAPEUTICS INC (1)
XOMA Corp (1)
ZAFGEN, INC. (2)
ZIOPHARM ONCOLOGY INC (1)

Recent Contracts

Agreement and Plan of Merger, dated as of November 25, 2024, by and among Poseida Therapeutics, Inc., Roche Holdings, Inc. and Blue Giant Acquisition Corp (Poseida Therapeutics, Inc., Filed With SEC on November 26, 2024)
Amendment No. 4 to Amended and Restated Merger Agreement (ADiTx Therapeutics, Inc., Filed With SEC on November 19, 2024)
Agreement and Plan of Merger, dated as of November 7 2024, by and among AlloVir, Inc., Aurora Merger Sub, Inc. and Kalaris Therapeutics, Inc (Allovir, Inc., Filed With SEC on November 8, 2024)
Agreement and Plan of Merger, dated as of November 6, 2024, by and among Space Finco, Inc., a Delaware corporation, Space Mergerco, Inc., a Delaware corporation, and Avid... (Avid Bioservices, Inc., Filed With SEC on November 7, 2024)
Agreement and Plan of Merger and Reorganization, dated as of October 28, 2024, by and among GlycoMimetics Biopharma, Inc., Gemini Merger Sub Corp., Gemini Merger Sub II, LLC and... (GLYCOMIMETICS INC, Filed With SEC on October 29, 2024)
Agreement and Plan of Merger, dated as of October 24, 2024, by and among ImmPACT Bio USA Inc., Lyell Immunopharma, Inc., Inspire Merger Sub Inc. and WT Representative LLC, solely... (Lyell Immunopharma, Inc., Filed With SEC on October 24, 2024)
Agreement and Plan of Merger, by and among Double Point Ventures LLC, DPV Parent, Inc., DPV MergerSub, Inc. and Lumos Pharma, Inc., dated October 22, 2024 (NEWLINK GENETICS CORP, Filed With SEC on October 23, 2024)
Waiver Agreement to Agreement and Plan of Merger, dated as of October 18, 2024, by and among Kintara Therapeutics, Inc., Kayak Mergeco, Inc., and TuHURA Biosciences, Inc (DelMar Pharmaceuticals, Inc., Filed With SEC on October 21, 2024)
Amendment No. 3 to Amended and Restated Merger Agreement (ADiTx Therapeutics, Inc., Filed With SEC on October 3, 2024)
Waiver Agreement to Agreement and Plan of Merger, dated as of September 25, 2024, by and among Kintara Therapeutics, Inc., Kayak Mergeco, Inc., and TuHURA Biosciences, Inc (DelMar Pharmaceuticals, Inc., Filed With SEC on September 25, 2024)
Amendment No. 2 to Amended and Restated Agreement and Plan of Merger dated as of September 6, 2024, by and among Aditxt, Inc., Adifem, Inc. and Evofem Biosciences, Inc (ADiTx Therapeutics, Inc., Filed With SEC on September 6, 2024)
Agreement and Plan of Merger, dated as of August 21, 2024, by and among the Company, Rafael, First Merger Sub and Second Merger Sub (CTD HOLDINGS INC, Filed With SEC on August 22, 2024)
Amendment No. 1 to Amended and Restated Merger Agreement (ADiTx Therapeutics, Inc., Filed With SEC on August 19, 2024)
Agreement and Plan of Merger, dated as of August 6, 2024, among the Company, Parent and Purchaser (pursuant to Item 601(a)(5) of Regulation S-K, the Company hereby agrees to... (G1 Therapeutics, Inc., Filed With SEC on August 7, 2024)
Agreement and Plan of Merger, dated as of July 23, 2024, by and among Pieris Pharmaceuticals, Inc., Polo Merger Sub, Inc. and Palvella Therapeutics, Inc (PIERIS PHARMACEUTICALS, INC., Filed With SEC on July 24, 2024)
Amended and Restated Agreement and Plan of Merger among Aditxt, Inc., Adifem, Inc. f/k/a Adicure, Inc. and Evofem Biosciences, Inc. dated as of July 12, 2024 (ADiTx Therapeutics, Inc., Filed With SEC on July 18, 2024)
Joint Venture Agreement between Bioxytran, the Heme Foundation and NDPD Pharma, dated July 15, 2024 (BIOXYTRAN, INC, Filed With SEC on July 17, 2024)
Agreement and Plan of Merger, by and among Morphic Holding, Inc., Eli Lilly and Company and Rainier Acquisition Corporation, dated July 7, 2024 (Morphic Holding, Inc., Filed With SEC on July 8, 2024)
Certificate of Ownership and Merger (Immix Biopharma, Inc., Filed With SEC on May 20, 2024)
Reinstatement and Fourth Amendment to the Merger Agreement dated May 2, 2024 (ADiTx Therapeutics, Inc., Filed With SEC on May 3, 2024)
Agreement and Plan of Merger, dated as of April 29, 2024, by and among Ono Pharmaceutical Co., Ltd., Topaz Merger Sub, Inc. and Deciphera Pharmaceuticals, Inc (Deciphera Pharmaceuticals, Inc., Filed With SEC on April 29, 2024)
Agreement and Plan of Merger, dated April 11, 2024, by and among the Company and the other parties thereto (Century Therapeutics, Inc., Filed With SEC on April 11, 2024)
Agreement and Plan of Merger and Reorganization, dated as of April 10, 2024, by and among Eliem Therapeutics, Inc., Tango Merger Sub, Inc., Tenet Medicines, Inc. and, solely in... (Eliem Therapeutics, Inc., Filed With SEC on April 11, 2024)
Agreement and Plan of Merger by and among Alpine Immune Sciences, Inc., Vertex Pharmaceuticals Incorporated and Adams Merger Sub, Inc., dated April 10, 2024 (ALPINE IMMUNE SCIENCES, INC., Filed With SEC on April 10, 2024)
Agreement and Plan of Merger and Reorganization, dated as of April 3, 2024, by and among ARCA biopharma, Inc., Atlas Merger Sub Corp., Atlas Merger Sub II LLC and Oruka... (ARCA biopharma, Inc., Filed With SEC on April 3, 2024)
Agreement and Plan of Merger, dated as of April 2, 2024, by and among Kintara Therapeutics, Inc., Kayak Mergeco, Inc., and TuHURA Biosciences, Inc (DelMar Pharmaceuticals, Inc., Filed With SEC on April 3, 2024)
Agreement and Plan of Merger and Reorganization (Emerald Bioscience, Inc., Filed With SEC on March 22, 2024)
Agreement and Plan of Merger, dated March 13, 2024, by and among First Wave BioPharma, Inc. IMMUNO Merger Sub I, Inc., IMMUNO Merger Sub II, LLC, and ImmunogenX, Inc (AzurRx BioPharma, Inc., Filed With SEC on March 14, 2024)
Form of Merger Warrant (Chardan Healthcare Acquisition Corp., Filed With SEC on March 6, 2024)
Agreement and Plan of Merger, dated March 6, 2024, by and among BiomX Inc., BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on March 6, 2024)
Third Amendment to Agreement and Plan of Merger dated as of February 29, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc (ADiTx Therapeutics, Inc., Filed With SEC on March 4, 2024)
Agreement and Plan of Merger, dated August 5, 2021, by and among EQRx, Inc. (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx,... (Revolution Medicines, Inc., Filed With SEC on February 26, 2024)
Agreement and Plan of Merger between the Company, Kinnate and Merger Sub, dated February 16, 2024 (XOMA Corp, Filed With SEC on February 16, 2024)
Agreement and Plan of Merger, dated February 16, 2024, by and among XOMA Corporation, XRA 1 Corp. and Kinnate Biopharma Inc (Kinnate Biopharma Inc., Filed With SEC on February 16, 2024)
Agreement and Plan of Merger, dated February 11, 2024, among CymaBay Therapeutics, Inc., Gilead Sciences, Inc. and Pacific Merger Sub, Inc (Gilead Sciences, Filed With SEC on February 12, 2024)
Second Amendment to Agreement and Plan of Merger dated as of January 8, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc (ADiTx Therapeutics, Inc., Filed With SEC on February 2, 2024)
Agreement and Plan of Merger, dated as of January 30, 2024, by and among AVRO, Aspen Merger Subsidiary, Inc. and Tectonic (AVROBIO, Inc., Filed With SEC on January 30, 2024)
Agreement and Plan of Merger, dated as of January 22, 2024, by and among Inhibrx, Inc., Aventis Inc., and Art Acquisition Sub, Inc (Inhibrx, Inc., Filed With SEC on January 23, 2024)
First Amendment to Agreement and Plan of Merger dated as of January 8, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc (ADiTx Therapeutics, Inc., Filed With SEC on January 9, 2024)
Agreement and Plan of Merger, by and among Merck Sharp & Dohme LLC, Harpoon Therapeutics, Inc., and Hawaii Merger Sub, Inc., dated January 7, 2024 (Harpoon Therapeutics, Inc., Filed With SEC on January 8, 2024)